Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,950.00p
   
  • Change Today:
    175.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 27,211
  • Market Cap: £154.13m

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £8,764,096
Ian James Nicholson 13,000 £383,500
Bruce Hiscock 1,236 £36,462

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £153,979,852
Castlefield Fund Partners Limited 985,000 £29,057,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £26,107,500
Gresham House Asset Management Limited 627,782 £18,519,569
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £18,275,250
Miton Group plc 508,135 £14,989,982
The Diverse Income Trust plc 302,300 £8,917,850
Schroders plc 284,795 £8,401,452
Wasatch Advisors, Inc. 265,000 £7,817,500
Canaccord Genuity Group Inc 259,940 £7,668,230
Adrian Williams 253,372 £7,474,474

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,950.00p
Change Today 175.00p
% Change 6.31 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 27,211
Shares Issued 5.22m
Market Cap £154.13m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.16% below the market average15.16% below the market average15.16% below the market average15.16% below the market average15.16% below the market average
48.94% above the sector average48.94% above the sector average48.94% above the sector average48.94% above the sector average48.94% above the sector average
Price Trend
63.16% below the market average63.16% below the market average63.16% below the market average63.16% below the market average63.16% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average
Income
43.99% above the market average43.99% above the market average43.99% above the market average43.99% above the market average43.99% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
17.21% below the market average17.21% below the market average17.21% below the market average17.21% below the market average17.21% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 20-May-2025

Time Volume / Share Price
16:35 1,200 @ 2,882.00p
16:25 1,000 @ 2,918.00p
16:25 1,000 @ 2,918.00p
11:31 10,000 @ 2,850.00p
16:42 9,500 @ 2,895.79p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page